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reliable communication and consistent goals. The second 
challenge was to provide a province-wide repository for sharing 
information and facilitating communication. In parallel with 
addressing these challenges, developmental work on 
streamlining and standardizing the RT process occurred. 
Results: The initial SC was assembled in Q1 2015; and full 
assembly of the SC and CG was completed in Q1 2016. The CG 
meets virtually on a weekly basis. The SC meets every ~6 weeks. 
Every second SC meeting is face-to-face at alternating RT centre 
locations. A Sharepoint site, accessible both inside and outside 
the organizational network, provides a central repository for 
information. RT process developments to-date include: 1) 
standard use of ARIA RO V11 MR 5.2 Prescribed Treatment 
workspace; 2) the entry of Diagnosis and Staging in ARIA RO; 3) 
standard definitions for a number of variables in our provincial 
minimum dataset; and 4) generation of an End of Treatment 
summary in ARIA RO with future distribution to other systems. 
Conclusions: The participation of all disciplines and facilities 
involved in the radiotherapy process is essential. Collaboration 
and communication between the four RT centres has greatly 
improved because of this project. North and South ARIA RO are 
now utilizing the same software versions and are converging in 
processes, carepaths, and definitions. The SC and CG provide a 
radiation oncology voice for communication with other provincial 
cancer control and healthcare initiatives. 
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Purpose: In 2011 the Canadian Partnership for Quality 
Radiotherapy (CPQR) released Quality Assurance Guidelines for 
Canadian Radiation Treatment Programs (QRT) recommending 
key quality indicators (KQI) of high quality, safe radiotherapy 
(RT). As it is unknown to what degree radiation oncology 
programs (ROP) use the guideline or meet these KQIs, we 
conducted a survey of Canadian ROPs to ascertain current 
guideline use and perceived barriers to its use as a self-auditing 
quality improvement (QI) tool.  
Methods and Materials: An invitation to participate was sent May 
2015 to all Canadian ROPs through their local CPQR 
representatives requesting one response per ROP (completed by 
December 2015). Each ROP was asked about use of the QRT 
document comprised of 47 KQI: 34 KQI scored as 0 (no) or1 (yes), 
and 13 KQI scored as a continuous variable of percentage 
compliance. To inquire about perceived barriers to unmet KQIs, 
personalized surveys were issued to each ROP based on results of 
their submitted self-audit of guideline KQIs.  
Results: The majority of ROPs completed the requested 
guideline self-audit (n = 44/45, 98%), with most (75%, 33/44) 
indicating previous use of the QRT. ROPs in the Prairies and 
Quebec accounted for 82% of centres (9/11) reporting no 
previous QRT use. Across ROP, there was a range of compliance 
for the 34 KQI scorable as 0 (no) or 1 (yes) (median 31/34, range 
19-34). Those binary KQIs identified as the most challenging 
included #22 (frequent policy and procedure review) with 50% 
compliant ROP (22/44) and #17 (RTQAC monitoring of technical 
quality control) with 66% compliant ROP (29/44). All 44 
responding ROP reported compliance with the following KQI: #32 
(RT prescription), #39 (on RT patient evaluation), #41 
(emergency RT policies/procedures) and #42 (RT plan record 
maintenance). Of the KQIs scored as a continuous variable, 
compliance was highest (100% median, range 60-100%) for #10 
(radiation oncologist certification) and lowest (median 50%, 
range 10-100%) for #33 (peer review pre-RT start). Two KQI 
appear particularly challenging, with only 59% (26/44) and 57% 
(25/44) of ROP responding regarding #44 (toxicity outcomes, 
median 30% ROP score, range 0-100%) and #45 (disease 
control/survival outcomes, median 25% ROP score, range 0-
100%), respectively. Commonly perceived barriers included lack 
of resources, data tracking ability or even disagreement with 
certain KQI. Many centres reported progress with unfulfilled 
KQIs, of which #2 and #3 (RTQAC monitoring and terms of 
reference) were most commonly cited. 
Conclusions: Since initial release of CPQR QRT, the majority of 
Canadian ROPs have used the guideline at least once to perform 
a quality self-audit. There are, however, gaps in guideline use 
and variations among centres in terms of KQI compliance. Future 
studies of potential facilitators to KQI uptake are warranted, as 
knowledge of perceived barriers may inform future strategies for 
optimizing QI initiatives across Canadian ROP. 
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Purpose: To evaluate leadership models in Canadian cancer 
centres, and assess leadership development programs within 
these centres.  
Methods and Materials: This mixed methods health services 
study was performed between August and October 2015 by the 
leadership of a Canadian cancer centre. It used literature 
review, a pan-Canadian survey and structured interviews with 
fifty administrative leads of free standing cancer centres 
registered with the Canadian Association of Provincial Cancer 
Agencies (40 invited to complete a written survey; 10 phone 
interviews). The survey consisted of 26 questions organized 
into categories such as: rating of current leadership; 
important elements of leadership; traits that identify emerging 
leaders; the use of competency frameworks to evaluate 
leaders and the availability of programs to improve skills in 
leaders. 
Results: Twenty three of the potential 50 participants (46%) 
provided responses including representation from all provinces. 
Synthesis of responses provided the following insights: 1) there 
is strong consensus about the effectiveness of current leaders 
and which elements of leadership are considered important; 2) 
good agreement was reached on the traits that identify emerging 
leaders; 3) it was clear that competency frameworks are not 
employed consistently. Fewer than 70% of respondents used the 
LEADS tool to evaluate their leaders; and 4) none of the 
respondents used formal succession planning tools. 75% of 
respondents did not systematically offer skill development 
programs to their leaders.  
Conclusions: Although current leaders are perceived as doing 
well at leading, there seemed to be several gaps needing 
attention. Firstly, there does not appear to be a consistent 
expectation of leaders needing to be regularly evaluated. 
Secondly, it is concerning that administrative and medical 
leaders within a significant number of Canadian cancer centres 
do not see the importance of providing opportunities to leaders 
that would maximize their skills to lead teams or drive innovative 
change. For cancer programs to thrive there needs to be greater 
attention to develop emerging leaders. 
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